Microbiome Restoration by RBX2660 Does Not Preclude Recurrence of Multidrug-Resistant Urinary Tract Infection Following Subsequent Antibiotic Exposure: A Case Report

A 62-year-old woman received RBX2660, an investigational microbiome restoration therapeutic, for recurrent multidrug-resistant (MDR) urinary tract infection (UTI). RBX2660 increased gut microbiome diversity but did not eliminate uropathogen carriage, and MDR UTI recurred after subsequent antibiotic...

Descripción completa

Detalles Bibliográficos
Autores principales: Keen, Eric C, Tasoff, Preston, Hink, Tiffany, Reske, Kimberly A, Burnham, Carey-Ann D, Dantas, Gautam, Kwon, Jennie H, Dubberke, Erik R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Brief Report (Fast track - FIDSA members only)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052748/
https://www.ncbi.nlm.nih.gov/pubmed/32154322
http://dx.doi.org/10.1093/ofid/ofaa042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052748/
https://www.ncbi.nlm.nih.gov/pubmed/32154322
http://dx.doi.org/10.1093/ofid/ofaa042

Ejemplares similares